LVMH 402.800 € (-2,30 %)
PROSUS 35.850 € (+0,17 %)
L'OREAL 376.050 € (-1,07 %)
VINCI 110.800 € (-1,86 %)
AXA 44.730 € (-0,73 %)
HERMES INTL 1 331.500 € (-3,16 %)
SANOFI 74.050 € (-1,61 %)
DANONE 60.540 € (-1,37 %)
BNP PARIBAS ACT.A 100.740 € (-2,93 %)
SAINT GOBAIN 69.120 € (-1,73 %)
AHOLD DEL 31.600 € (-1,22 %)
AIRBUS 193.380 € (-1,08 %)
AIR LIQUIDE 163.160 € (-1,26 %)
SCHNEIDER ELECTRIC 285.750 € (-0,47 %)
NEXITY 5.255 € (-3,58 %)
ALTAREA 85.300 € (-0,70 %)
WOLTERS KLUWER 68.160 € (-2,74 %)
PERNOD RICARD 59.440 € (-1,13 %)
SHELL PLC 41.315 € (-0,59 %)
UBISOFT ENTERTAIN 5.308 € (-2,61 %)
EUROFINS SCIENT. 76.440 € (-0,57 %)
MYHOTELMATCH 0.125 € (+16,90 %)
AKZO NOBEL 56.080 € (-0,74 %)
CSG 15.432 € (-4,07 %)
ALSTOM 15.280 € (-2,64 %)
VINPAI 2.600 € (-18,75 %)
CEGEDIM 10.500 € (-0,19 %)
MAUREL ET PROM 8.270 € (0,00 %)
EXAIL TECHNOLOGIES 124.500 € (0,00 %)
GECINA 65.500 € (-1,43 %)
SES 4.758 € (-3,25 %)
VIVENDI SE 1.493 € (-2,61 %)
ASM INTERNATIONAL 813.800 € (+2,91 %)
ARCELORMITTAL SA 63.120 € (-3,69 %)
DASSAULT SYSTEMES 20.560 € (-0,10 %)
MICHELIN 33.080 € (-1,37 %)
LEGRAND 135.800 € (-0,37 %)
CHRISTIAN DIOR 369.200 € (-2,17 %)
PHARMING GROUP 0.917 € (-2,28 %)
EUTELSAT COMMUNIC. 1.753 € (-2,99 %)
CAPGEMINI 104.350 € (-2,57 %)
LAKEFRONT BIOTHER. 24.980 € (+0,16 %)
2CRSI 28.360 € (-1,39 %)
HOPIUM 0.004 € (+2,94 %)
EURAZEO 46.420 € (-0,85 %)
HAFFNER ENERGY BSA 0.010 € (-20,83 %)
CREDIT AGRICOLE 18.190 € (-2,23 %)
EXOR NV 68.500 € (-4,06 %)
MAAT PHARMA 1.630 € (-18,50 %)
CORBION 22.660 € (+0,98 %)
ADP 108.300 € (-0,37 %)
ENGIE 24.030 € (-0,91 %)
MERCIALYS 10.480 € (-2,24 %)
BE SEMICONDUCTOR 186.650 € (+2,84 %)
CATERING INTL SCES 21.800 € (+9,55 %)
IMERYS 22.440 € (-0,88 %)
BOUYGUES 43.380 € (-3,28 %)
BRUNEL INTERNAT 7.220 € (-0,55 %)
UMG 14.750 € (+0,07 %)
ACOMO 23.000 € (-1,08 %) |
07/09/2026 07:00
AEVIS VICTORIA SA (AEVS.SW) – Swiss Medical Network significantly improves profitability in the first half of 2026AEVIS VICTORIA SA / Key word(s): Half Year Results Press release Fribourg, 7 September 2026 AEVIS VICTORIA SA (AEVS.SW) – Swiss Medical Network significantly improves profitability in the first half of 2026 EBITDAR up 18.8% and EBITDA up 32.6%, with further earnings improvement expected from ongoing restructuring Swiss Medical Network Holding SA, the healthcare subsidiary of AEVIS VICTORIA SA («AEVIS»), recorded a strong improvement in profitability in the first half of 2026. EBITDAR increased by 18.8% to CHF 94.0 million and EBITDA by 32.6% to CHF 46.0 million, driven by continued operational improvements across the hospital network and the further development of ambulatory and primary care activities. Total revenue of the Healthcare segment increased by 12.4% to CHF 563.5 million in the first six months of 2026, compared with CHF 501.4 million in the prior-year period. As previously communicated with the first-quarter results, the increase in reported total revenue mainly reflects the changed presentation of independent physicians’ fees introduced in 2025. Net revenue, which provides a more meaningful measure of the underlying development of activity, increased by 2.1% to CHF 435.0 million. On an organic basis, net revenue increased by 1.4%. Profitability developed significantly faster than revenue. EBITDAR increased by 18.8% to CHF 94.0 million, corresponding to a margin of 21.6%, compared with CHF 79.2 million and 18.6% in the first half of 2025. EBITDA rose by 32.6% to CHF 46.0 million, with the margin increasing to 10.6% from 8.1% last year. EBIT more than doubled to CHF 15.1 million, compared with CHF 6.3 million in the prior year period. On an organic basis, EBITDAR and EBITDA increased by 17.5% and 30.0%, respectively. Strong performance of the hospital network These results still include the negative impact related to Privatklinik Lindberg of close to CHF 2 million on EBITDA level during the first half of 2026. Following the transfer of its medical activities to Privatklinik Bethanien in Zurich and Privatklinik Belair in Schaffhausen, the Lindberg premises will be taken over by Kantonsspital Winterthur as of 1 October 2026. The restructuring will therefore only have a limited positive effect on the 2026 results, while its full impact will become visible in 2027. Ambulatory and primary care activities continue to improve The first-time consolidation of Radiologia Ticino contributed CHF 2.8 million to net revenue and CHF 1.0 million to EBITDAR during the period. Excluding this change in scope, ambulatory net revenue grew organically by 1.5%, while EBITDAR increased organically by 48.6%. Integrated care strategy progressing The strong first-half performance, the continued improvement of the ambulatory platform and the measures already implemented within the hospital network provide a solid basis for the further development of Swiss Medical Network in the second half of 2026 and into 2027. AEVIS will publish its full Half-Year Report 2026, including detailed information on Swiss Medical Network and its other participations, on 17 September 2026. For further information: About Swiss Medical Network AEVIS VICTORIA SA – Investing for a better life End of Media Release 2394572 07.09.2026 CET/CEST Source : Webdisclosure.com |
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière